WAYNE, PA--(Marketwire - Nov 16, 2011) - Kenexa (
In making its decision, Lilly sought to consolidate many of its global recruitment processes with an experienced pharmaceutical expert such as Kenexa, in order to increase efficiencies in the end-to-end recruiting process. Lilly and Kenexa share a strong presence in several global growth markets which further established synergies between the companies.
Rudy Karsan, CEO of Kenexa, commented, "Improving outcomes, enriching lives is the mantra of Kenexa's relationship with Lilly. Kenexa is proud to be an integral part of Lilly's global recruiting program."
"Our selection process was rigorous and Kenexa met our expectations by showcasing their global RPO services capabilities and providing access to their centers of excellence in Asia, Europe, and the Americas," said Nancy Lange, senior director for Global Recruiting and Staffing for Lilly. "The company demonstrated their strengths in integrating services, technology, and relevant content."
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.
About Kenexa
Kenexa (